Alpizar F
Department of Obstetrics and Gynecology, Hospital San Rafael, Alajuela, Costa Rica.
Int J Gynaecol Obstet. 2003 Oct;83 Suppl 2:S141-5. doi: 10.1016/S0020-7292(03)90107-X.
To evaluate the safety, efficacy and acceptability of quinacrine sterilization (QS) in Costa Rica.
From 1989 though August 1993, 694 women volunteered for QS in my private practice. All were referred by a family planning clinic or a local hospital obstetric service. The protocol used involved the transcervical insertion of 216 mg of quinacrine hydrochloride in the form of 6 pellets. A second dose was given 4 weeks later. All insertions were done in the first 14 days of the menstrual cycle. The procedure was similar to the CuT IUD placement. Temporary contraception was recommended for 3 months after the last insertion. The cut-off date for this analysis was April 1994.
With 7 months to 5 years of follow-up, the gross pregnancy rate was 2.5%. Side effects were relatively minor, none requiring hospitalization.
QS was found to be safe, effective and acceptable.
评估奎纳克林绝育法(QS)在哥斯达黎加的安全性、有效性和可接受性。
1989年至1993年8月期间,694名女性在我的私人诊所自愿接受QS。她们均由计划生育诊所或当地医院产科服务机构转诊而来。所采用的方案是经宫颈插入6粒含216毫克盐酸奎纳克林的药丸。4周后给予第二剂。所有插入操作均在月经周期的前14天进行。该操作与放置铜T宫内节育器相似。建议在最后一次插入后3个月内采取临时避孕措施。本次分析的截止日期为1994年4月。
经过7个月至5年的随访,总妊娠率为2.5%。副作用相对较小,无人需要住院治疗。
发现QS安全、有效且可接受。